A5040974260- Pain Management and Opioid Use
- Anesthesia and Pain Management
- Cardiovascular Syncope and Autonomic Disorders
- Pain Management and Treatment
- Musculoskeletal pain and rehabilitation
- Spine and Intervertebral Disc Pathology
- Pain Mechanisms and Treatments
- Pain Management and Placebo Effect
- Pediatric Pain Management Techniques
- Glycogen Storage Diseases and Myoclonus
- Epilepsy research and treatment
- Anesthesia and Sedative Agents
- Botulinum Toxin and Related Neurological Disorders
- Urological Disorders and Treatments
- Sexual function and dysfunction studies
- Myofascial pain diagnosis and treatment
- Genital Health and Disease
- Pediatric Urology and Nephrology Studies
- Sexuality, Behavior, and Technology
- Lymphatic System and Diseases
- Sympathectomy and Hyperhidrosis Treatments
- Scoliosis diagnosis and treatment
- Lymphatic Disorders and Treatments
- Urologic and reproductive health conditions
- Anorectal Disease Treatments and Outcomes
Integrated Solutions for Systems (United States)
2012-2024
Moss Rehabilitation Hospital
2017
Louisiana State University Health Sciences Center New Orleans
2017
Université de Poitiers
2017
Columbus Oncology and Hematology Associates
2008
The University of Texas MD Anderson Cancer Center
1990-1991
The Ohio State University
1987-1988
The Ohio State University Wexner Medical Center
1988
Nationwide Children's Hospital
1988
A 26-year experience with all aspects of priapism is reviewed in 105 children and adults. The etiology the was idiopathic or drug-induced, owing to sickle cell disease, trauma, neoplasia, leukemia, papaverine-phentolamine injections total parenteral alimentation. pathophysiology prolonged erection discussed. Treatment respect initial studies before type shunting procedure required selected. Various shunt techniques are presented outcome. Complications their possible causes discussed,...
Abstract Background The Patient Registry of Intrathecal Ziconotide Management ( PRIZM ) evaluated long‐term effectiveness, safety, and tolerability intrathecal ziconotide treatment in clinical practice. Methods was an open‐label, long‐term, multicenter, observational study adult patients with severe chronic pain. This interim analysis (data through July 10, 2015) as the first vs. not agent pump included change from baseline Numeric Pain Rating Scale NPRS ; primary efficacy measure) Global...
Diuretic renography frequently is used to assess obstruction in hydronephrosis of infancy but it invalidated by poor renal function, which occurs this age group. In an attempt establish a guideline determine when function too rely on diuretic for accurate diagnosis we analyzed the slope renographic washout curve normal, nonaffected kidney 33 infants with unilateral hydronephrosis. When T 1/2 time was greater than 9 minutes, as occurred 68 per cent less 1 month old, defined significant...
Abstract Background and Objectives The Patient Registry of Intrathecal Ziconotide Management evaluated the long-term effectiveness safety intrathecal ziconotide. Methods study was a prospective, multicenter observational ziconotide in US clinical practice. Patients were adults with severe chronic pain that warranted therapy. initiated as single agent pump; however, other medications permitted. primary efficacy outcome ≥30% reduction numeric rating scale score from baseline at week 12. A...
Introduction Intrathecal therapy has been limited by non-randomized prospective studies, particularly for those suffering from non-cancer. Further, no prospective, randomized studies investigating the efficacy, safety, and utilization of intrathecal polyanalgesic consensus guidelines exist.Methods After IRB approval, patients were enrolled in a 1:1 fashion drug delivery (IDD) or conventional management (CMM), employing standard care, excluding delivery, based on principal investigator’s...